Format

Send to

Choose Destination
Horm Res. 2002;58 Suppl 3:49-55.

Osteoporosis and the growth hormone-insulin-like growth factor axis.

Author information

1
Department of Rheumatology, University Hospital, Maastricht, The Netherlands. piet.geusens@ping.be

Abstract

Osteoporosis is the result of an imbalance between bone resorption and bone formation. Currently, mainly drugs that inhibit bone resorption are available for the treatment of osteoporosis. A new approach in the treatment of osteoporosis is the use of anabolic agents that increase bone turnover, both bone formation and resorption. Growth hormone (GH) and insulin-like growth factors (IGFs) are essential in the development and growth of the skeleton and for the maintenance of bone mass and density. We will review the evidence of GH and IGF-I in the pathophysiology and treatment of osteoporosis.

PMID:
12435898
DOI:
10.1159/000066483
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center